Advertisement

Prophylaxe und konservative Therapie des ANV

  • W. H. Hörl
Part of the Klinische Anästhesiologie und Intensivtherapie book series (KAI, volume 45)

Zusammenfassung

Klinische und tierexperimentelle Studien der letzten Jahre offerieren neue Konzepte in der Prophylaxe und konservativen Therapie des akuten Nierenversagens (ANV). Im folgenden sollen bewährte Maßnahmen diesen neuen Therapievorstellungen gegenübergestellt bzw. die bewährte Therapie durch die neuen Konzepte ergänzt werden.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Agatstein ER, Farrer JH, Kaplan LM (1987) The effect of verapamil in reducing the severity of acute tubular necrosis in canine renal autotransplants. Transplantation 44: 335–357CrossRefGoogle Scholar
  2. 2.
    Bakris GL, Burnett JC (1985) A role for calcium in radiocontrast-induced reductions in renal hemodynamics. Kidney Int 27: 465–468PubMedCrossRefGoogle Scholar
  3. 3.
    Bank N, Better OS (1991) Acid-base disturbances in acute renal failure. Miner Electrolyte Metab 17: 116–123PubMedGoogle Scholar
  4. 4.
    Better OS, Stein JH (1990) Early management of shock and prophylaxis of acute renal failure in traumatic rhabdomyolysis. N Engl J Med 322: 825–829PubMedCrossRefGoogle Scholar
  5. 5.
    Better OS, Ben-Haim SA, Edoute Y (1990) Effect of hypertonic mannitol (M) on contractility of isolated working rat heart. J Am Soc Nephrol 1: 593 (Abstr)Google Scholar
  6. 6.
    Better OS (1992) Post-traumatic acute renal failure: pathogenesis and prophylaxis. Nephrol Dial Transplant 7: 260–2MPubMedGoogle Scholar
  7. 7.
    Better OS, Zinman C, Reis ND et al. (in press) Hypertonic mannitol ameliorates intracompartmental tamponade in model compartment syndrome in the dog. NephronGoogle Scholar
  8. 8.
    Burke TJ, Cronin RE, Duchin KL, Peterson LN, Schrier RW (1980) Ischemia and tubule obstruction during acute renal failure in dogs: mannitol in protection. Am J Physiol 238: F305 — F314PubMedGoogle Scholar
  9. 9.
    Burke TJ, Arnold PE, Gordon JA, Bulger RE, Dobyan DC, Schrier RW (1984) Protective effect of intra-renal calcium membrane blockers before or after renal ischemia: Functional, morphological and mitochondrial studies. J Clin Invest 74: 1830–1841PubMedCrossRefGoogle Scholar
  10. 10.
    Conger JD, Falk SA, Hammond WS (1991) Atrial natriuretic peptide and dopamine in established acute renal failure in the rat. Kidney Int 40: 21–28PubMedCrossRefGoogle Scholar
  11. 11.
    Docci D (1984) Dopamine-furosemide in oliguric acute renal failure. Nephron 36: 74PubMedCrossRefGoogle Scholar
  12. 12.
    Druml W, Schneeweiss B, Grimm G (1989) Parenteral nutrition in acute renal failure. In: Hartig W, Dietze G, Weiner R, Fürst P (eds) Nutrition in clinical pratice. Proc 10th Congress ESPEN. Karger, Basel, pp 192–203Google Scholar
  13. 13.
    Duggan KA, Mac Donald GJ, Charlesworth JA, Pussel BA (1988) Verapamil prevents posttransplant oliguric renal failure. Clin Nephrol 24: 289–291Google Scholar
  14. 14.
    Flores J, DiBona DR, Beck CH, Leaf A (1972) The role of cell swelling in ischemic renal damage and the protective effect of hypertonic solute. J Clin Invest 51: 118–126PubMedCrossRefGoogle Scholar
  15. 15.
    Garza-Quintero R, Ortega-Lopez J. Stein JH, Venkatachalam MA (1990) Alanine protects rabbit proximal tubules against anoxic injury in vitro. Am J Physiol 258: F1075 — F1083Google Scholar
  16. 16.
    Gianello P, Squifflet JP, Cartier M et al. (1989) Evidence that atrial natriuretic factor is the humoral factor by which volume loading or mannitol infusion produces an improved renal function after acute ischemia. An experimental study in dogs. Transplantation 48: 9–14PubMedCrossRefGoogle Scholar
  17. 17.
    Götz R. Bausewein K, Heidbreder E et al. (1989) Acute renal failure in the intensive care unit Are there benefits of atrial natriuretic factor in dopamine/furosemide resistant acute renal failure? (Abstr). Kidney 35: 282Google Scholar
  18. 18.
    Götz R, Heidbreder E, Landwehr G et al. (1990) Impaired response to intrarenal administered atrial natriuretic peptide in ischemic acute renal failure of a transplant patient. Miner Electrolyte Metab 16: 34–37PubMedGoogle Scholar
  19. 19.
    Goldfarb D, laina A, Serbon I, Govendo S, Koupler S, Eliahou HE (1983) Beneficial of verapamil in ischemic acute renal failure in the rat. Proc Soc Exp Biol Med 172: 389–392PubMedGoogle Scholar
  20. 20.
    Graziani G, Cantaluppi A, Casati S et al. (1984) Dopamine and frusemide in oliguric acute renal failure. Nephron 37: 39–42PubMedCrossRefGoogle Scholar
  21. 21.
    Greger R, Wangemann P (1987) Loop diuretics. Renal Physiol 10: 174–183Google Scholar
  22. 22.
    Hanley MJ, Davidson K (1981) Prior mannitol and furosemide infusion in a model of ischemic acute renal failure. Am J Physiol 241: F556–564PubMedGoogle Scholar
  23. 23.
    Heidbreder E, Schafferhans K, Schramm D, Götz R, Heidland A (1986) Toxic renal failure in the rat: Beneficial effects of atrial natriuretic factor. Klin Wochenschr 64 (Suppl 6): 78–82PubMedGoogle Scholar
  24. 24.
    Heidbreder E, Zollner L Schafferhans K, Götz R (1990) Atrial natriuretic peptide reverses experimental acute renal failure induced by arginine vasopressin. Miner Electrolyte Metab 16: 48–53PubMedGoogle Scholar
  25. 25.
    Heymann SN, Rosen S, Silva P, Spokes K, Egorin MJ, Epstein FH (1991) Protective action of glycine in cisplatin nephrotoxicity. Kidney Int 40: 273–279CrossRefGoogle Scholar
  26. 26.
    Kopp KF (1981) Prophylaxe des akuten Nierenversagens (ANV) mit Hilfe der Bikarbonat-Diurese (BD). Inensivmedizin 18: 254–260Google Scholar
  27. 27.
    Kunzendorf U, Walz G, Brockmöller J, Neumayer HH, Jochimsen F Roots I, Offermann G, Strom TB (1991) Effects of diltiazem upon metabolism and immunosuppresive action of cyclosporine in kidney graft recipients. Transplantation 52: 280–284PubMedCrossRefGoogle Scholar
  28. 28.
    Lazarus JM (1990) Prophylaxis of acute renal failure in the intensive care unit. In: Bihari D, Neild G eds Acute renal failure in the intensive therapy unit. Springer, Berlin Heidelberg New York Tokyo, pp 279–309Google Scholar
  29. 29.
    Lee SM, Michael OF (1985) The protectice effect of nitrendipine on gentamicin acute renal failure in rats. Exp Mol Pathol 43: 107–114PubMedCrossRefGoogle Scholar
  30. 30.
    Levinsky NG, Bernard DB (1988) Mannitol and loop diuretics in acute renal failure. In: Brenner BM, Lazarus JM (ed) Acute renal failure, 2nd edn. Churchill Livingstone, New York, pp 841–856Google Scholar
  31. 31.
    Linder A, Cutler RE, Goodman WG (1979) Synergism of dopamine plus furosemide in preventing acute renal failure in the dog. Kidney Int 16: 158–166CrossRefGoogle Scholar
  32. 32.
    Lindner A (1983) Synergism of dopamine and furosemide in diuretic-resistant, oligurie acute renal failure. Nephrom 33: 121–126CrossRefGoogle Scholar
  33. 33.
    Malis CD, Cheung JX, Leaf AL, Bonventre JV (1983) Effects of verapamil in models of ischemic acute renal failure in the rat. Am J Physiol 245: F735 — F742PubMedGoogle Scholar
  34. 34.
    Moursi M, Rising CL, Zelenock GB, D’Alecy LG (1987) Dextrose administration exacerbates acute renal ischemic damage in anesthetized dogs. Arch Surg 122: 790–794PubMedGoogle Scholar
  35. 35.
    Nakamoto M, Shapiro JI, Shanley PF, Chan L, Schrier RW (1987) In vitro and in vivo protective effect of atriopeptin III on ischemic acute renal failure. J Clin Invest 80: 698–705PubMedCrossRefGoogle Scholar
  36. 36.
    Neumayer HH, Wagner K (1987) Calciumantagonisten and Gewebeprotektion. Intensivmedizin 24: 149–162Google Scholar
  37. 37.
    Neumayer HH, Junge W, Küfner A, Wenning A (1989) Prevention of radiocontrastmedia-induced nephrotoxicity by the calcium channel blocker nitrendipine: A prospective randomised clinical trial. Nephrol Dial Transplant 4: 1030–1036PubMedGoogle Scholar
  38. 38.
    Pafrey PS, Griffiths SM, Barrett BJ et al. (1989) Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med 320: 143–149CrossRefGoogle Scholar
  39. 39.
    Podrazik RM, Natale JE, Zelenock GB, D’Alecy LG (1989) Hyperglycemia exacerbates and insulin fails to protect in acute renal ischemia in the rat. J Surg Res 46: 572–578PubMedCrossRefGoogle Scholar
  40. 40.
    Porush JG, Chou SX, Anto HR, Oguagha C, Shapiro WB, Faubert PF (1982) Infusion intravenous pyelography and renal function: effects of hypertonic mannitol and furosemide in patients with chronic renal insufficiency. In: Eliahou HE (ed) Acute renal failure. Libbey, London, pp 161–167Google Scholar
  41. 41.
    Racusen LC, Finn WF, Whelton A, Solez K (1985) Mechanisms of lysine induced acute renal failure in rats. Kidney Int 27: 517–522PubMedCrossRefGoogle Scholar
  42. 42.
    Rooth P, Dawidson I, Diller K, Täljedal IB (1988) Protection against cyclosporine-induced impairment of renal microcirculation by verapamil in mice. Transplantation 45: 433–437PubMedCrossRefGoogle Scholar
  43. 43.
    Russo D, Testa A, Della Volpe L, Sansone G (1990) Randomised prospective study on renal effects of two different contrast media in humans: Protective role of a calcium channel blocker. Nephron 55: 254–257PubMedCrossRefGoogle Scholar
  44. 44.
    Sawaya BP, Weihprecht H, Campbell WR, Lorenz JN, Webb RC, Briggs JP, Schnermann J (1991) Direct vasoconstruition as a possible cause for amphotericin B-induced nephrotoxicity in rats. J Clin Invest 87: 2097–2107PubMedCrossRefGoogle Scholar
  45. 45.
    Schafferhans K, Heidbreder E, Grimm D, Heidland A (1986) Norepinephrine-induced acute renal failure: Beneficial effects of atrial natriuretic factor. Nephron 44: 240–244PubMedCrossRefGoogle Scholar
  46. 46.
    Schafferhans K, Heidbreder E, Sperber S, Dämmrich J, Heidland A (1988) Atrial natriuretic peptide in gentamicin-induced acute renal failure. Kidney Int 34 (Suppl 25): S-101—S-103Google Scholar
  47. 47.
    Schafferhans K, Heidbnreder E, Hummel S, Heidland A (1988) Atrial natriuretic peptide counteracts angiotension-II-induced impairment of renal function. Z Kardiol 77 (Suppl 2): 78–84PubMedGoogle Scholar
  48. 48.
    Schrier RW, Arnold PE, Van Putten VJ, Burke TJ (1987) Cellular calcium in ischemic acute renal failure: Role of calcium entry blockers. Kidney Int 32: 313–321PubMedCrossRefGoogle Scholar
  49. 49.
    Schwab SJ, Hlatky MA, Pieper KS, Davidson CJ, Morris KG, Skelton TN, Bashore TM (1989) Contrast nephrotoxicity: A randomized controlled trial of a nonionic and an ionic radiographic contrast agent. N Engl J Med 320: 149–153PubMedCrossRefGoogle Scholar
  50. 50.
    Shaw SG, Weidmann P, Hodler J, Zimmermann A, Patemostro A (1987) Atrial natriuretic peptide protects against acute ischemic renal failure in the rat. J Clin Invest 80: 1232–1237PubMedCrossRefGoogle Scholar
  51. 51.
    Sleijfer DT, Offerman JJG, Mulder NH, Verweij M, Van der Hem GK, Schraffordt Koops HS, Meijer S (1987) The protective potential of the combination of verapamil and cimetidine on cislatin-induced nephrotoxicity in man Cancer 60: 2823–2828Google Scholar
  52. 52.
    Solez K, Stout R, Bendush B, Silvia CB, Whelton A (1982) Adverse effect of amino acid solutions in aminoglycoside-induced acute renal failure in rabbits and rats. In: Eliahou HE (ed) Acute renal failure. Libbey, London, pp 241–247Google Scholar
  53. 53.
    Sumpio B, Baue AE, Chaudry IH (1987) Treatment with verapamil and adenosine triphosphate-MgCl2 reduces cyclosporine nephrotoxicity. Surgery 101: 315–322PubMedGoogle Scholar
  54. 54.
    Tolins JP, Raij L (1991) Chronic amphotericin B nephrotoxicity in the rat: protective effect of calcium channel blockade. J Am Soc Nephrol 2: 98–102PubMedGoogle Scholar
  55. 55.
    Wait RB, White G, David JH (1983) Beneficial effects of verapamil on postischemic renal failure. Surgery 94: 276–282PubMedGoogle Scholar
  56. 56.
    Weinberg JM, Davis JA, Abarzua M, Rajan T (1987) Cytoprotective effects of glycine and glutathione against hypoxic injury to renal tubules. J Clin Invest 80: 1446–1454PubMedCrossRefGoogle Scholar
  57. 57.
    Weinberg JM, Davis JA, Abarzua M, Kiani I Kunkel R (1990) Protection by glycine of proximal tubules from injury due to inhibits of mitochondrial ATP production. Am J Physiol 258: C1127 — C1140Google Scholar
  58. 58.
    Weinberg JM (1991) The cell biology of ischemic renal injury. Kidney Int 39: 476–500PubMedCrossRefGoogle Scholar
  59. 59.
    Teschner M, Heidland A (1985) Nutrition in acute renal failure. Blood Purif 3: 170–175PubMedCrossRefGoogle Scholar
  60. 60.
    Yamasaki Y, Nishiuchi T; Kojima A et al. (1988) Effects of an oral water load and intravenous administration of isotonic glucose, hypertonic saline, mannitol and furosemide on the release of atrial natriuretic peptide in men. Acta Endocrinol 119: 269–276PubMedGoogle Scholar
  61. 61.
    Zager RA, Venkatachalam MA (1983) Potentiation of ischemic renal injury by amino acid infusion. Kidney Int 24: 620–625PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1993

Authors and Affiliations

  • W. H. Hörl

There are no affiliations available

Personalised recommendations